demonstrated that UB not only prevents the development of CRC but also modifies the gut microbiota and enhances the immunological environment of tumors, leading to reduced PD-L1 expression and improved outcomes when combined with traditional therapies. The gene discussed is CD274; the disease is colorectal carcinoma.